Code · BILL · 115th Congress · S. 2680 (Introduced in Senate) — To address the opioid crisis. · Sec. 304

Sec. 304. Clarifying FDA post-market authorities

44 words·~1 min read·/bill/115/s/2680/is/section-304

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 505–1(b)(1)(E) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355–1(b)(1)(E) ) is amended by striking of the drug and inserting of the drug, which may include reduced effectiveness that is not in accordance with the labeling of such drug .

Connections1 off-index

1 reference not yet in our index

21 USC 355–1(b)(1)(E)

Citation graph

cites case law

Sec. 304

Clarifying FDA post-market authorities

Cite21 USC 355–1(b)(1)(E)

Cites 1Cited by 0 across 0 sources